Literature DB >> 8486954

Acid dissociation of immune complexes improves diagnostic utility of p24 antigen detection in perinatally acquired human immunodeficiency virus infection.

T C Quinn1, R Kline, M W Moss, R A Livingston, N Hutton.   

Abstract

Since acid treatment of serum is known to disrupt immune complexes, the diagnostic utility of the p24 antigen assay was examined after acid treatment of 345 serum samples from 158 children born to women infected with human immunodeficiency virus (HIV). Although the p24 antigen assay after acid treatment was negative in 9 HIV-1-infected children < 1 week old, antigen was detectable at high levels in all 30 samples obtained from infected children 1-9 months old. Overall, antigen was positive in 145 (sensitivity 89.5%) of 162 samples from 47 HIV-1-infected children > or = 1 month old. In contrast, the sensitivity of the p24 antigen assay without acid dissociation was only 18% (P < .001). Among the 76 uninfected children, 132 (specificity 99.2%) of 133 specimens were p24 antigen-negative after acid dissociation. These results demonstrate that acid treatment of serum markedly improves the sensitivity and predictive value of the p24 antigen assay for diagnosis of perinatally acquired HIV-1 infection in children 1 month of age or older.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486954     DOI: 10.1093/infdis/167.5.1193

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  Uses of flow cytometry in virology.

Authors:  J J McSharry
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

2.  Stabilities of free and complexed human immunodeficiency virus p24 antigens during short- and long-term storage.

Authors:  M Arens; W Meyer; D Brambilla; J Bremer; S Fiscus; B Griffith; S Hammer; R Hodinka; W Kabat; B Yen-Lieberman; L Myers; P Reichelderfer
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  Detection of vertical transmission of human immunodeficiency virus type 1 by a commercial polymerase chain reaction assay.

Authors:  P Bermúdez; P Moreno; R Delgado; J T Ramos; J Ruiz-Contreras; A R Noriega
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

4.  Diagnosis of human immunodeficiency virus type 1 infection in infants by immune complex dissociation p24 assay.

Authors:  M O Paul; G Toedter; D Hofheinz; S Tetali; S Pelton; M Marecki; A Brena; E J Abrams; S Landesman; S Pahwa
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

5.  Practical application of acid dissociation in monitoring patients treated with adalimumab.

Authors:  Francisca Llinares-Tello; José Rosas-Gómez de Salazar; José Miguel Senabre-Gallego; Gregorio Santos-Soler; Carlos Santos-Ramírez; Esteban Salas-Heredia; Xavier Barber-Vallés; Juan Molina-García
Journal:  Rheumatol Int       Date:  2014-05-10       Impact factor: 2.631

6.  Ultrasensitive p24 antigen assay for diagnosis of perinatal human immunodeficiency virus type 1 infection.

Authors:  Susan A Fiscus; Jeffrey Wiener; Elaine J Abrams; Marc Bulterys; Ada Cachafeiro; Richard A Respess
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

7.  An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.

Authors:  Einar M Sigurdsson; Elin Knudsen; Ayodeji Asuni; Cheryl Fitzer-Attas; Daniel Sage; David Quartermain; Fernando Goni; Blas Frangione; Thomas Wisniewski
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

8.  Sensitivity of immune complex-dissociated p24 antigen testing for early detection of human immunodeficiency virus in infants.

Authors:  D E Lewis; A Adu-Oppong; F B Hollinger; H M Rosenblatt; I C Hanson; J M Reuben; M W Kline; C A Kozinetz; W T Shearer
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

9.  Stability of free and complexed human immunodeficiency virus type 1 antigen at 4 degrees C and at room temperature.

Authors:  B P Griffith; R B Garner; T M Chacko
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

10.  Development of a method that eliminates false-positive results due to nerve growth factor interference in the assessment of fulranumab immunogenicity.

Authors:  Sheng Dai; Allen Schantz; Adrienne Clements-Egan; Michael Cannon; Gopi Shankar
Journal:  AAPS J       Date:  2014-03-05       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.